Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-4632.2012.05653.x | DOI Listing |
J Obstet Gynaecol India
June 2024
Apollo Hospital, Navi Mumbai, India.
Cureus
May 2024
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, USA.
Cornea
November 2024
Department of Ophthalmology and Visual Sciences, University of Michigan W.K. Kellogg Eye Center, Ann Arbor, MI; and.
J Oral Maxillofac Pathol
January 2021
Core Diagnostics Private Limited, Gurgaon, Haryana, India.
Hidradenoma Papilliferum (HP) is a rare, benign, cutaneous adnexal tumor of middle-aged females arising mainly in the apocrine sweat glands of perianal and genital region. Initially, HP was considered to be an apocrine sweat gland tumor however recent research showed that it descends from the anogenital mammary-like glands, HP can be regarded theoretically as the cutaneous complement of mammary intraductal papilloma. Nongenital HP is an infrequent manifestation, ectopic forms of this entity have been defined with bulk of them occurring on the head and neck region (60%) and 85% of cases being 1.
View Article and Find Full Text PDFCureus
February 2021
Colorectal Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
Hidradenoma papilliferum (HP) is a benign pathologic finding that has been described primarily in the vulvar region. While thought to arise from ectopic tissue along the mammary line, it is now known to also arise from mammary-like anogenital glands (MLG), which are part of the normal anogenital cellular and glandular milieu. Previous work has demonstrated the relationship between HP and hormone receptors, but this has not been documented in a clinical setting.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!